Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in vasodilator effects of platelet-activating factor in resistance vessels of spontaneously hypertensive

K Kamata1, T Numazawa, Y Kasuya

  • 1Department of Physiology and Morphology, Hoshi University, Tokyo, Japan.

European Journal of Pharmacology
|July 11, 1994
PubMed
Summary

Platelet-activating factor (PAF) causes less vasodilation in hypertensive rats, suggesting endothelial desensitization, not impairment, is responsible for reduced effects in these models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gaiter of pellagra.

QJM : monthly journal of the Association of Physicians·2022
Same author

Gut microbiome alterations in type 1 autoimmune pancreatitis after induction of remission by prednisolone.

Clinical and experimental immunology·2020
Same author

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Multiple gout tophi.

QJM : monthly journal of the Association of Physicians·2018
Same author

Comparison of Bispectral Index and Entropy values with electroencephalogram during surgical anaesthesia with sevoflurane.

British journal of anaesthesia·2015
Same author

Crescentic glomerulonephritis with antimyeloperoxidase antibodies developing during the course of IgA nephropathy in a patient with rheumatoid arthritis.

Modern rheumatology·2014

Area of Science:

  • Cardiovascular Physiology
  • Endothelial Function
  • Vascular Biology

Background:

  • Platelet-activating factor (PAF) is a potent mediator involved in inflammation and vascular tone.
  • Endothelial dysfunction is a hallmark of hypertension, impacting vasodilation.
  • Spontaneously hypertensive rats (SHRs) serve as a model for human essential hypertension.

Purpose of the Study:

  • To investigate the endothelium-dependent vasodilator effects of PAF in Wistar Kyoto rats (WKYs) and SHRs.
  • To compare the mesenteric arterial bed's response to PAF between normotensive and hypertensive rat models.
  • To elucidate the mechanisms underlying altered PAF-induced vasodilation in hypertension.

Main Methods:

  • Mesenteric arterial beds from WKYs and SHRs were isolated and perfused.

Related Experiment Videos

  • Vasodilator responses to cumulative doses of PAF were measured.
  • Reactivity and sensitivity to acetylcholine were assessed as controls.

    • Main Results:

    • PAF-induced vasodilation was significantly attenuated in the mesenteric arterial bed of SHRs compared to WKYs.
    • No significant differences in mesenteric reactivity or sensitivity to acetylcholine were observed between WKYs and SHRs.
    • These findings indicate a specific alteration in the response to PAF in the hypertensive model.

    Conclusions:

    • The attenuated vasodilator effect of PAF in SHRs is likely due to desensitization of the endothelium, rather than a general impairment.
    • Endothelial cells in SHRs may exhibit reduced responsiveness to PAF signaling pathways.
    • This desensitization could contribute to impaired vascular function in hypertension.